David Chen
Resident - General Surgery
Providence Health and Services
4805 NE Glisan St., Suite 2N35, Portland, OR, 97209, United States
About
Fellowship Cardiothoracic Surgery, New York University Langone Health.
New York University, New York, NY, 2019 - 2022
Residency General Surgery, Beth Israel Deaconess Medical Center
Harvard Medical School, Boston, MA, 2017-2019
Fellowship Cancer Immunotherapy & Surgical Oncology, National Cancer Institute
National Institutes of Health, Bethesda MD, 2014 – 2017
Residency General Surgery, St. Luke’s – Roosevelt Hospital Center
Icahn School of Medicine at Mount Sinai, New York NY, 2011 – 2014
Education MD, New York Medical College
Valhalla NY, 2007 – 2011
BS, Applied Economics & Management, Cornell University
Ithaca NY, 2003 – 2007
New York University, New York, NY, 2019 - 2022
Residency General Surgery, Beth Israel Deaconess Medical Center
Harvard Medical School, Boston, MA, 2017-2019
Fellowship Cancer Immunotherapy & Surgical Oncology, National Cancer Institute
National Institutes of Health, Bethesda MD, 2014 – 2017
Residency General Surgery, St. Luke’s – Roosevelt Hospital Center
Icahn School of Medicine at Mount Sinai, New York NY, 2011 – 2014
Education MD, New York Medical College
Valhalla NY, 2007 – 2011
BS, Applied Economics & Management, Cornell University
Ithaca NY, 2003 – 2007
Research
Fellowship Cancer Immunotherapy & Surgical Oncology, National Cancer Institute
National Institutes of Health, Bethesda MD, 2014 – 2017
Clinical Fellow, Surgery Branch, July 2016 – June 2017
• PI: Steven A. Rosenberg, MD, PhD, clinical care of patients enrolled in intramural cancer immunotherapy protocols
Research Fellow, Surgery Branch, January 2015 – June 2016
• PI: James Yang, MD, translational laboratory research focused on identification of a T-cell receptor targeting mutant KRAS
Clinical Fellow, Thoracic & Gastrointestinal Oncology Branch / Endocrine Oncology Branch, July 2014 – December 2014
• Clinical care of patients enrolled in intramural surgical oncology protocols
Practice Areas
Cancer
Organizations
Other Interests
Cell therapy, solid malignancy immunotherapy, translational research